PMSO yields 2000000.00% · PFE yields 6.13%● Live data
📍 PMSO pulled ahead of the other in Year 1
Combined, PMSO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PMSO + PFE for your $10,000?
Primal Solutions, Inc. develops and provides managed software solutions to communications service providers. Its solutions enable communications service providers to automatically capture, correlate, track, manage, monetize, and analyze their communications transaction data. The company's services include applications management services; business process outsourcing services; local and remote data center services; professional services, which comprise planning, business process consulting, training, and implementation support; and customer support services. Its solutions support voice, data, or video services. The company's solutions are used in 70 paging, cellular, wire line, fiber, and hybrid fiber-coaxial networks to support subscribers and transactions. It sells its products through direct sales force and channel partners primarily in the United States. The company was formerly known as Primal Systems, Inc. and changed its name to Primal Solutions, Inc. in October, 1999. The company was incorporated in 1996 and is based in Irvine, California. Primal Solutions, Inc. is a former subsidiary of Billing Services Group Limited.
Full PMSO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.